Indonesia’s Siloam Hospital Implements First da Vinci Xi Surgical System

Aug 2025

Siloam Hospitals, one of Indonesia’s largest private hospital networks, has begun implementing the da Vinci Xi robotic-assisted surgery system developed by Intuitive Surgical. This marks the first deployment of the da Vinci Xi system in Indonesia, bringing a widely adopted robotic surgical technology known for supporting surgeons in minimally invasive procedures to the hospital.

Siloam Hospitals’ adoption of robotic surgery technology represents a continuation of its digital transformation efforts, which began in 2016 with the consolidation of its disparate information systems. This installation of the RAS system follows the 2024 implementation of Philips’ AI solutions across radiology, pathology, interventional cardiology, and clinical operations.

During the unveiling of the RAS system at Siloam Hospitals, the Indonesian Health Minister announced that he has directed public university hospitals to mandate laparoscopic skill development for aspiring general surgeons, aiming to address the shortage of digestive surgeons across 514 cities. Additionally, the Minister emphasized his commitment to accelerating the adoption of robotic surgery in Indonesia, highlighting the country’s current lag behind neighboring Southeast Asian nations in this area.

In January 2024, the Indonesian government expanded its robotic telesurgery project with Iran, building on a pilot initiative conducted the year before. This effort is part of the government’s telemedicine strategy aimed at improving access to quality healthcare in remote communities. Additionally, the government approved an Indian-made robotic-assisted surgery (RAS) system developed by SS Innovations, which the company states has been clinically validated across more than 70 types of surgical procedures.

Earlier in 2025, Alfred Hospital in Australia introduced its second robotic surgical system, also supplied by Intuitive Surgical. The da Vinci Xi system is utilized to assist surgeons in performing a variety of minimally invasive procedures, particularly for cancer and cardiothoracic cases.

(Source: Healthcare IT News)

About Us

Orissa International helps companies that want to develop a market entry strategy for Southeast Asia or implement their business expansion into the region. We have very strong domain knowledge of markets and industry sectors, and a business network of over 15,000 companies that includes distributors, resellers, system integrators and local manufacturers, that we have built through advising and guiding more than 4,000 companies with their market expansion into the ASEAN region over the last 28 years.

Orissa International is headquartered in Singapore, with additional offices in Malaysia, Indonesia, Thailand, Vietnam, and the Philippines.

Our Services